Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
20
NCT03752905
A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 9, 2019
Completion: Nov 30, 2020
NCT04599881
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
Phase: Phase 2
Start: Oct 15, 2020
Completion: Sep 1, 2021
NCT05143190
Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)
Start: Dec 2, 2021
Completion: Aug 9, 2022